UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST

£100 million public-private investment establishes 20 research hubs across the UK, part of the VPAG Investment Programme. These Commercial Research Delivery Centres (CRDCs) will conduct state-of-the-art clinical trials in various medical fields, supported by the National Institute for Health and Care Research. The initiative aims to enhance the UK's life sciences sector, provide early access to treatments, and boost economic growth.

The NIHR is investing £72 million to establish 14 new Commercial Research Delivery Centres (CRDCs) in England to enhance commercial clinical research speed and efficiency. These centres will support UK's status as a top research location, decentralize clinical trials to community settings, and ensure research inclusion for all eligible communities. Funded by the VPAG Investment Programme and NIHR, the initiative aims to boost UK's life sciences sector and economic growth.

£100 million public-private investment to set up 20 research hubs across the UK, enhancing access to cutting-edge treatments and clinical trials in community settings, boosting economic growth and research delivery leadership in various medical conditions.

Biologic drugs for asthma can be used during conception, pregnancy, and breastfeeding with shared decision-making. Use should be recorded in registries, and restarting after birth is recommended if halted. Inactivated vaccinations for infants are safe even if mothers received biologics. Concerns remain due to limited clinical trial data, especially for newer biologics like tezepelumab.